News
-
-
PRESS RELEASE
Conversion to registered shares with a new ISIN DE000A41YHG1 is proceeding as planned – temporary discrepancies in portfolio displays are possible
Alzchem Group AG is progressing in the conversion to registered shares with a new ISIN DE000A41YHG1 as planned. Temporary discrepancies in portfolio displays are possible -
-
-
-
-
-
PRESS RELEASE
mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
mAbxience and Sandoz sign a collaboration agreement to advance biosimilar access worldwide, combining development and commercial expertise to broaden patient access to high-quality biologic medicines -
-